Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Cognitive Control and Metacognition to Reduce the Functional Impact of Restricted and Repetitive Behaviors in Autism

NCT06885684 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT06885684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06885684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Cognitive Control and Metacognition to Reduce the Functional Impact of Restricted and Repetitive Behaviors in Autism
Lead sponsor
Boston Children's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
June 30, 2028
Enrollment
95 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autism spectrum disorder